Art

J-GLOBAL ID：201602212966414830   Reference number：16A1213008

Nucleobindin 2 (NUCB2) in human endometrial carcinoma: a potent prognostic factor associated with cell proliferation and migration

ヒト子宮内膜癌におけるヌクレオビンディン2(NUCB2):細胞増殖および遊走と関連する有力な予後因子

Author (8)： Takagi Kiyoshi (Departments of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai, Japan) ,  Miki Yasuhiro (Department of Disaster Obstetrics and Gynecology, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan) ,  Tanaka Sota (Departments of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Japan) ,  Hashimoto Chiaki (Departments of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Japan) ,  Watanabe Mika (Department of Pathology, Tohoku University Hospital, Sendai, Japan) ,  Sasano Hironobu (Departments of Anatomic Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan) ,  Ito Kiyoshi (Department of Disaster Obstetrics and Gynecology, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan) ,  Suzuki Takashi (Departments of Pathology and Histotechnology, Tohoku University Graduate School of Medicine, Sendai, Japan)
Material： Endocrine Journal  (Endocr J)
Volume： 63  Issue： 3  Page： 287-299(J-STAGE)  Publication year： 2016 
JST Material Number： F0625A  ISSN： 0918-8959  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *ヌクレオビンディン2 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1213008&from=J-GLOBAL&jstjournalNo=F0625A") }}

Author keywords (5)： NUCB2 ,  Endometrial cancer ,  Prognosis ,  Biomarker ,  Immunohistochemistry

JST classification (3)： Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N) ,  Tumors(=neoplasms)of female genitalia and fetus  (GS04000K) ,  Biological function  (EB03040U)

Reference (38)：

• 1. Kato T, Watari H, Endo D, Mitamura T, Odagiri T, et al. (2012) New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system. J Surg Oncol 106: 938-941.
• 2. Lanciano RM, Greven KM (1995) Adjuvant treatment for endometrial cancer: who needs it? Gynecol Oncol 57: 135-137.
• 3. Ball HG (1996) Do we know the best therapy for early endometrial cancer? Gynecol Oncol 60: 173-175.
• 4. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, et al. (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355: 1404-1411.
• 5. Orr JW Jr, Roland PY, Leichter D, Orr PF (2001) Endometrial cancer: is surgical staging necessary? Curr Opin Oncol 13: 408-412.

Terms in the title (5)： ヒト ,  子宮内膜癌 ,  細胞増殖 ,  遊走 ,  予後因子